alpha-1-Antitrypsin Deficiency, Autosomal Recessive

PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that are considered investigational or… (More)

BACKGROUND Pulmonary rehabilitation (PR) improves oxidative capacity of peripheral muscles in patients with chronic obstructive… (More)

Registrational trials in rare and orphan diseases present complexities related to the identification of subjects, recruitment… (More)

Sarcoidosis is a systemic disease characterized by noncaseating granulomatous inflammation with tremendous clinical heterogeneity… (More)

Disclosure: David Parr has received honoraria for advising CSL Behring and Grifols (formerly Talecris), in addition to… (More)

Severe deficiency of alpha-1 antitrypsin has a highly variable clinical presentation. The Genomic Research in Alpha-1 Antitrypsin… (More)

Augmentation therapy in Alpha-1 Antitrypsin Deficiency aims to reduce the progression of lung emphysema, to reduce exacerbation… (More)

UNLABELLED . BACKGROUND Currently, there is a remarkable lack of genetic epidemiological studies on alpha 1-antitrypsin (AAT… (More)

This present paper describes the general characteristics, objectives and organizational aspects of the respiratory disease… (More)

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820 Goals, Organization of the Project, and… (More)